Strategic Investment Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
929
+184
+25% +$188K 0.25% 68
2026
Q1
$685K Buy
745
+3
+0.4% +$3.04K 0.17% 81
2025
Q4
$797K Buy
742
+1
+0.1% +$956 0.19% 73
2025
Q3
$565K Buy
741
+12
+2% +$8.93K 0.15% 88
2025
Q2
$569K Buy
729
+51
+8% +$39.6K 0.17% 78
2025
Q1
$560K Buy
678
+1
+0.1% +$832 0.16% 68
2024
Q4
$523K Buy
677
+1
+0.1% +$828 0.17% 67
2024
Q3
$599K Buy
676
+52
+8% +$46.8K 0.18% 66
2024
Q2
$144K Buy
+624
New +$499K 0.05% 110
2023
Q4
$373K Sell
640
-39,521
-98% -$23.1M 0.06% 131
2023
Q3
$20.7M Buy
40,161
+39,525
+6,215% +$20.4M 0.26% 63
2023
Q2
$277K Hold
636
0.06% 111
2023
Q1
$218K Buy
636
+2
+0.3% +$675 0.04% 172
2022
Q4
$210K Buy
+634
New +$225K 0.1% 88

Other funds holding LLY

Strategic Investment Solutions's LLY Position: Q2 2026 in Review

Strategic Investment Solutions increased its Eli Lilly (LLY) stake by 25% in Q2 2026, buying an estimated $188K and bringing the position to 929 shares worth $1.11M. The position accounts for 0.25% of the portfolio, ranked #68.

Strategic Investment Solutions first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $20.7M in Q3 2023. 1,805 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Strategic Investment Solutions held 929 shares of Eli Lilly worth $1.11M as of Q2 2026.
  • Strategic Investment Solutions bought 184 Eli Lilly shares in Q2 2026, an estimated $188K.
  • Eli Lilly made up 0.25% of Strategic Investment Solutions's portfolio in Q2 2026, its #68 holding.
  • Strategic Investment Solutions first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Strategic Investment Solutions's Eli Lilly position peaked at $20.7M in Q3 2023.
  • 1,805 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.